148 related articles for article (PubMed ID: 29028174)
1. Could Frequent Carbapenem Use Be a Risk Factor for Colistin Resistance?
Gundogdu A; Ulu-Kilic A; Kilic H; Ozhan E; Altun D; Cakir O; Alp E
Microb Drug Resist; 2018; 24(6):774-781. PubMed ID: 29028174
[TBL] [Abstract][Full Text] [Related]
2. Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality.
Rojas LJ; Salim M; Cober E; Richter SS; Perez F; Salata RA; Kalayjian RC; Watkins RR; Marshall S; Rudin SD; Domitrovic TN; Hujer AM; Hujer KM; Doi Y; Kaye KS; Evans S; Fowler VG; Bonomo RA; van Duin D;
Clin Infect Dis; 2017 Mar; 64(6):711-718. PubMed ID: 27940944
[TBL] [Abstract][Full Text] [Related]
3. Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit.
Timofte D; Dan M; Maciuca IE; Ciucu L; Dabija ER; Guguianu E; Panzaru CV
Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2069-74. PubMed ID: 26239064
[TBL] [Abstract][Full Text] [Related]
4. Outbreaks of colistin-resistant and colistin-susceptible KPC-producing Klebsiella pneumoniae in a Brazilian intensive care unit.
Rossi Gonçalves I; Ferreira ML; Araujo BF; Campos PA; Royer S; Batistão DW; Souza LP; Brito CS; Urzedo JE; Gontijo-Filho PP; Ribas RM
J Hosp Infect; 2016 Dec; 94(4):322-329. PubMed ID: 27654515
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study.
Giacobbe DR; Del Bono V; Trecarichi EM; De Rosa FG; Giannella M; Bassetti M; Bartoloni A; Losito AR; Corcione S; Bartoletti M; Mantengoli E; Saffioti C; Pagani N; Tedeschi S; Spanu T; Rossolini GM; Marchese A; Ambretti S; Cauda R; Viale P; Viscoli C; Tumbarello M;
Clin Microbiol Infect; 2015 Dec; 21(12):1106.e1-8. PubMed ID: 26278669
[TBL] [Abstract][Full Text] [Related]
6. Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.
Qureshi ZA; Hittle LE; O'Hara JA; Rivera JI; Syed A; Shields RK; Pasculle AW; Ernst RK; Doi Y
Clin Infect Dis; 2015 May; 60(9):1295-303. PubMed ID: 25632010
[TBL] [Abstract][Full Text] [Related]
7. Multiple importations and transmission of colistin-resistant
Mathur P; Khurana S; de Man TJB; Rastogi N; Katoch O; Veeraraghavan B; Neeravi AR; Venkatesan M; Kumar S; Sagar S; Gupta A; Aggarwal R; Soni KD; Malhotra R; Velayudhan A; Siromany V; Malpiedi P; Lutgring J; Laserson K; Gupta N; Srikantiah P; Sharma A
Infect Control Hosp Epidemiol; 2019 Dec; 40(12):1387-1393. PubMed ID: 31625832
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend.
Balkhair A; Al-Muharrmi Z; Al'Adawi B; Al Busaidi I; Taher HB; Al-Siyabi T; Al Amin M; Hassan KS
Int J Infect Dis; 2019 Aug; 85():10-15. PubMed ID: 31100418
[TBL] [Abstract][Full Text] [Related]
9. Colistin resistance increases 28-day mortality in bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae.
Balkan II; Alkan M; Aygün G; Kuşkucu M; Ankaralı H; Karagöz A; Şen S; Arsu HY; Biçer M; Kaya SY; Karaali R; Mete B; Saltoğlu N; Tabak F
Eur J Clin Microbiol Infect Dis; 2021 Oct; 40(10):2161-2170. PubMed ID: 33963928
[TBL] [Abstract][Full Text] [Related]
10. Molecular Mechanisms of Colistin Resistance in
Liu Y; Lin Y; Wang Z; Hu N; Liu Q; Zhou W; Li X; Hu L; Guo J; Huang X; Zeng L
Front Cell Infect Microbiol; 2021; 11():673503. PubMed ID: 34765565
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for the Development of Colistin Resistance during Colistin Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections.
Huang PH; Chen WY; Chou SH; Wang FD; Lin YT
Microbiol Spectr; 2022 Jun; 10(3):e0038122. PubMed ID: 35652641
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and mechanisms of in vivo emergence of colistin resistance in carbapenem-resistant Klebsiella pneumoniae.
Huang PH; Cheng YH; Chen WY; Juan CH; Chou SH; Wang JT; Chuang C; Wang FD; Lin YT
Int J Antimicrob Agents; 2021 Jun; 57(6):106342. PubMed ID: 33864932
[TBL] [Abstract][Full Text] [Related]
13. Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs.
Mezzatesta ML; Caio C; Gona F; Cormaci R; Salerno I; Zingali T; Denaro C; Gennaro M; Quattrone C; Stefani S
Int J Antimicrob Agents; 2014 Aug; 44(2):112-6. PubMed ID: 25059444
[TBL] [Abstract][Full Text] [Related]
14. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
[TBL] [Abstract][Full Text] [Related]
15. Collateral damage of using colistin in hospitalized patients on emergence of colistin-resistant
Wangchinda W; Pati N; Maknakhon N; Seenama C; Tiengrim S; Thamlikitkul V
Antimicrob Resist Infect Control; 2018; 7():84. PubMed ID: 30026942
[TBL] [Abstract][Full Text] [Related]
16. Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin and tigecycline resistance.
Meletis G; Oustas E; Botziori C; Kakasi E; Koteli A
New Microbiol; 2015 Jul; 38(3):417-21. PubMed ID: 26147150
[TBL] [Abstract][Full Text] [Related]
17. An Update of the Evolving Epidemic of blaKPC Carrying Klebsiella pneumoniae in Sicily, Italy, 2014: Emergence of Multiple Non-ST258 Clones.
Bonura C; Giuffrè M; Aleo A; Fasciana T; Di Bernardo F; Stampone T; Giammanco A; ; Palma DM; Mammina C
PLoS One; 2015; 10(7):e0132936. PubMed ID: 26177547
[TBL] [Abstract][Full Text] [Related]
18. Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.
Khawcharoenporn T; Pruetpongpun N; Tiamsak P; Rutchanawech S; Mundy LM; Apisarnthanarak A
Int J Antimicrob Agents; 2014 Apr; 43(4):378-82. PubMed ID: 24613422
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity of carbapenem-based combinations againts multidrug-resistant Acinetobacter baumannii.
Pongpech P; Amornnopparattanakul S; Panapakdee S; Fungwithaya S; Nannha P; Dhiraputra C; Leelarasamee A
J Med Assoc Thai; 2010 Feb; 93(2):161-71. PubMed ID: 20301995
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of dual colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A single-center retrospective study of 75 cases in India.
Kaur A; Gandra S; Gupta P; Mehta Y; Laxminarayan R; Sengupta S
Am J Infect Control; 2017 Nov; 45(11):1289-1291. PubMed ID: 28807425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
